Seroepidemiology of human T-cell lymphotropic virus among Iranian adult thalassemic patients

Transfusion Medicine

Volumn 24, Issue 4, 2014, Pages 227-232

  Keshvari, M ^a,b   Hajibeigi, B ^a   Azarkeivan, A ^a   Keyvani, H ^c   Behnava, B ^b   Saiedi Hosseini, S Y ^b   Sharafi, H ^b   Alavian, S M ^b  

^a HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^b Middle East Liver Diseases Center (MELD Centers)   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HTLV; Iran; Thalassemia

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; IRAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; SEROEPIDEMIOLOGY; SEROPREVALENCE; SPLENECTOMY; THALASSEMIA; VIRUS TRANSMISSION; WESTERN BLOTTING; ADVERSE EFFECTS; BLOODBORNE BACTERIUM; DELTARETROVIRUS; DELTARETROVIRUS INFECTIONS; TRANSMISSION;

ADULT; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; DELTARETROVIRUS; DELTARETROVIRUS INFECTIONS; FEMALE; HUMANS; IRAN; MALE; SEROEPIDEMIOLOGIC STUDIES; THALASSEMIA;

EID: 84905859497     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/tme.12133     Document Type: Article

References (38)

1. Abbaszadegan, M.R., Gholamin, M., Tabatabaee, A., Farid, R., Houshmand, M. & Abbaszadegan, M. (2003) Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran. Journal of Clinical Microbiology, 41, 2593-2595.
2. Abedi, F., Yavarian, M., Shakibzadeh, A., Khalvati, B. & Asadi, A. (2009) A pilot seroepidemiologic study of HTLV in thalassemia, hemophilia, and hemodialysed patients in Hormozgan. Medical Journal of Hormozgan University, 13, 75-80.
3. Abolghasemi, H., Amid, A., Zeinali, S. et al. (2007) Thalassemia in Iran: epidemiology, prevention, and management. Journal of Pediatric Hematology/Oncology, 29, 233-238.
4. Alavian, S.M., Kafaee, J., Yektaparast, B., Hajarizadeh, B. & Doroudi, T. (2002) The efficacy of blood donor screening in reducing the incidence of hepatitis C virus infection among thalassemic patients in Iran. Transfusion Today, 53, 3-4.
5. Anaraki Mohammadi, G., Sadeghipour, A., Vossough, P., Nour Mohammadi, I. & Mirnateghi, A. (2005) Assessment of the prevalence of human T-lymphotropic virus type 1 among thalassemic patients with frequent blood transfusion in Tehran in 2003. Razi Journal of Medical Sciences, 12, 19-24.
6. Ardalan, N., Abdi, M., Zarif, B., Amini, A., Memary, F., Haydari, E. & Ahmadi, A. (2013) Prevalence of human T-lymphotropic virus types I&II among high risk groups in Sanandaj in 2010. Scientific Journal of Kurdistan University of Medical Sciences, 18, 51-57.
7. Arjmandi, F., Shahriari, M. & Sadeghi Hasanabadi, M. (2002) A comparitive study of the prevalence of HTLV-I infection in leukemia/non-hodgkins lymphoma patients, thalassemic patients and blood donors. Journal of Shahid Sadoughi University of Medical Sciences and Health Services, 10, 25-29.
8. Aydinok, Y. (2012) Thalassemia. Hematology, 17 (Suppl. 1), S28-S31.
9. Azarkeivan, A., Karimi, G., Shaiegan, M., Maghsudlu, M. & Tabbaroki, A. (2009) Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect). Pediatric Hematology and Oncology, 26, 195-201.
10. Chang, Y.B., Kaidarova, Z., Hindes, D. et al. (2014) Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors - United States, 2000-2009. The Journal of Infectious Diseases, 4, 523-531.
11. Chaudhary, R. & Phadke, S.R. (2001) Absence of HTLV-I infection in multi-transfused thalassemia patients in North India. American Journal of Hematology, 67, 217-218.
12. Ghaderi, A. & Habib-Agahi, M. (1996) High prevalence of anti-HCV and HTLV-1 antibodies in thalassemia major patients of Southern Iran. Iranian Journal of Medical Sciences, 21, 2.
13. Ghadiri, K., Rezaei, M., Payandeh, M. & ErfanZare, M. (2011) Serologic prevalence of human T-lymphotropic virus (HTLV) among major thalassemic patients in Kermanshah 2010. International Journal of Hematology-Oncology and Stem Cell Research, 5, 14-17.
14. Ghaffari, J., Kowsarian, M., Mahdavi, M., Vahid Shahi, K., Rafatpanah, H. & Tafreshian, A. (2012) Prevalence of HTLV-I infection in patients with thalassemia major in Mazandaran, North of Iran. Jundishapur Journal of Microbiology, 6, 57-60.
15. Hedayati-Moghaddam, M.R. (2013) A systematic review for estimation of HTLV-I infection in the blood donors of Iran. Iranian Journal of Basic Medical Sciences, 16, 196-201.
16. Karimi, A., Nafici, M. & Imani, R. (2007) Comparison of human T-cell leukemia virus type-1 (HTLV-1) seroprevalence in high risk patients (thalassemia and hemodialysis) and healthy individuals from Charmahal-Bakhtiari province, Iran. Kuwait Medical Journal, 39, 259-261.
17. Karimi, G., Gharehbaghian, A., Tafti, M.F. & Vafaiyan, V. (2013) Emerging infectious threats to the blood supply: seroepidemiological studies in Iran - a review. Transfusion Medicine and Hemotherapy, 40, 210-217.
18. Khabbaz, R.F., Onorato, I.M., Cannon, R.O., Hartley, T.M., Roberts, B., Hosein, B. & Kaplan, J.E. (1992) Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. New England Journal of Medicine, 326, 375-380.
19. Mansouritorghabeh, H. & Badiei, Z. (2008) Transfusion-transmitted viruses in individuals with β thalassemia major at Northeastern Iran, a retrospective sero-epidemiological survey. Iranian Journal of Blood & Cancer, 1, 1-4.
20. Milagres, F.A., Duarte, M.I., Viso, A.T. & Segurado, A.C. (2009) Hepatitis C virus and human T-lymphotropic virus coinfection: epidemiological, clinical, laboratory and histopathological features. Revista da Sociedade Brasileira de Medicina Tropical, 42, 363-368.
21. Milani, S. & Shooshtari, M. (2010) Study on efficacy of hepatitis B immunization in vaccinated beta-thalassemia children in Tehran. Iranian Journal of Pediatrics, 20, 211-215.
22. Mirmomen, S., Alavian, S.-M., Hajarizadeh, B. et al. (2006) Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: a multicenter study. Archives of Iranian Medicine, 9, 319-323.
23. Moradi, A., Yaghob-Nezhad, Z., Mohagheghi, A. et al. (2003) Seroepidemiology of HTLV-1 antibody in the thalassemic patients in Zahedan and Zaboul cities in 2001. Journal of Zanjan University of Medical Sciences and Health Services, 43, 43-47.
24. Moradi, A., Mansurian, A., Ahmadi, A., Ghaemi, E., Kalavi, K., Marjani, A. & Moghaddam, E.S. (2008) Prevalence of HTLV-1 antibody among major thalassemic patients in Gorgan (South East of Caspian Sea). Journal of Applied Sciences, 8, 391-393.
25. Mortezaie, Z., Bouzari, M. & Roghanian, R. (2012) Evaluating the frequency of HTLV-I/II infection among blood donors, major thalassemic patients and individuals infected with hepatitis B and C viruses in Isfahan, Iran. Iranian Journal of Blood & Cancer, 1, 169-175.
26. Mozzi, F., Rebulla, P., Lillo, F., Varnier, O.E., Biadati, C., Calcagno, L., Melotti, S. & Sirchia, G. (1992) HIV and HTLV infections in 1305 transfusion-dependent thalassemics in Italy. The COOLEYCARE Cooperative Group. AIDS, 6, 505-508.
27. Poorolajal, J. & Majdzadeh, R. (2009) Prevalence of chronic hepatitis B infection in Iran: a review article. Journal of Research in Medical Sciences, 14, 249-258.
28. Pourkarim, M., Hajiani, G.R., Khamisipour, G.R., Ardeshirdavani, N. & Tahmasebi, R. (2005) Seroepidemiological investigation of HTLV I, II infection among Busherian multi-transfused patients in 2003. Blood (Khoon), 2, 99-104.
29. Proietti, F.A., Carneiro-Proietti, A.B.F., Catalan-Soares, B.C. & Murphy, E.L. (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene, 24, 6058-6068.
30. Rafatpanah, H., Hedayati-Moghaddam, M.R., Fathimoghadam, F. et al. (2011) High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. Journal of Clinical Virology, 52, 172-176.
31. Rezaee, A.R., Banoei, M.M., Khalili, E. & Houshmand, M. (2012) Beta-thalassemia in Iran: new insight into the role of genetic admixture and migration. The Scientific World Journal, 2012, 635183.
32. Rezvan, H., Ahmad, J. & Farhadi, M. (1996) A cluster of HTLV-1 infection in northeastern of Iran. Transfusion Today, 27, 8-11.
33. Safai, B., Huang, J.L., Boeri, E., Farid, R., Raafat, J., Schutzer, P., Ahkami, R. & Franchini, G. (1996) Prevalence of HTLV type I infection in Iran: a serological and genetic study. AIDS Research and Human Retroviruses, 12, 1185-1190.
34. Salimi, S., Alavian, S.M., Behnava, B., Keshvari, M., Keyvani, H., Mehrnoush, L., Gholami Fesharaki, M. & Karimi, P. (2013) The prevalence of HTLV-I infection in Iranian thalassemic and haemophilic patients with chronic hepatitis C. Hepatology International, 7 (Suppl. 1), S399.
35. Shindo, N., Alcantara, L.C., Van Dooren, S. et al. (2002) Human retroviruses (HIV and HTLV) in Brazilian Indians: seroepidemiological study and molecular epidemiology of HTLV type 2 isolates. AIDS Research and Human Retroviruses, 18, 71-77.
36. Switzer, W.M., Shankar, A., Trimble, S.R. et al. (2013) Human T cell lymphotropic virus type 1 infection among US thalassemia patients. AIDS Research and Human Retroviruses, 29, 1006-1009.
37. Tarhini, M., Kchour, G., Zanjani, D.S., Rafatpanah, H., Otrock, Z.K., Bazarbachi, A. & Farid, R. (2009) Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology, 41, 498-499.
38. Tseliou, P.M., Spanakis, N., Spiliotakara, A., Markogiannakis, A., Legakis, N.J. & Tsakris, A. (2006) Prevalence of infection by HTLV-I/II among pregnant women and high-risk groups in the Peloponnese peninsula, Greece. International Journal of STD & AIDS, 17, 543-546.